While technology behemoths and up-and-coming startups are often cited as the industry’s top disruptors, it’s innovative payment models and big data that will likely have the greatest impact on home health care delivery over the next several years, experts predict.
Additionally, as long as gaps exist throughout the hospital-to-home transition process, further disruption is sure to come from non-medical home care providers and entities operating on the fringes of the in-home care space.
“Somewhere between a $3,000 home health episode and going home with nothing, there’s a gap in care for people who might not need intense home health care, but need some support and assistance with the transition from hospital-to-home,” Tony D’Alonzo, director of clinical strategy and innovation for Bayada Home Health Care, said.
D’Alonzo highlighted macro-level trends and other factors disrupting the home health industry during an April 10 panel discussion at Home Health Care News’ Capital + Strategy Forum in Washington, D.C.
Rexanne Domico, president of home health care and rehabilitation services for BrightSpring Health Services, joined D’Alonzo on the panel. As did Dr. Roy Beveridge — who recently retired from his role as chief medical officer for insurance giant Humana Inc. (NYSE: HUM).
With more than 28,000 employees and 360 offices in nearly two dozen states, Moorestown, New Jersey-based Bayda is one of the largest home health providers in the country. In addition to its U.S. footprint, Bayada operates across six countries. Read the full article